Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Should You Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $23.50, but opened at $26.44. Anbio Biotechnology shares last traded at $26.44, with a volume of 275 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, February 9th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Anbio Biotechnology has an average rating of “Hold”.

Anbio Biotechnology Stock Up 0.7%

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings results on Tuesday, December 30th. The company reported $0.04 earnings per share for the quarter. The firm had revenue of $2.29 million for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.